4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-24-027918
Chief Financial Officer sold 1,792 shares at $18.73 ($33,560)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FRATES JAMES M Chief Financial Officer | 2024-03-05 | Sale | −1,792 | $18.73 | $33,560 | 134,784 | D |
| Open-market sales · 1,792 sh · avg $18.73 · $33,560 | |||||||
Loading xslF345X05/ownership.xml…